
Follow for #endocrinology news and coverage of all major endocrinology meetings! Peer-reviewed and #endocrinologist-trusted. @MedPageToday | #EndoTwitter
Joined January 2019
- Tweets1.9K
- Following45
- Followers1.3K
- Likes1.8K
Pinned Tweet
Check out @medpagetoday's new medical word guessing game, #Wordosis! Test your knowledge with 6 chances to guess the medical word of the day! #MedTwitter #EndoTwitter
medpagetoday.com/wordosis?xi…
MedPage Endocrinology retweeted
"The study doesn't actually give a stamp of approval to run off and take testosterone." -- Bradley Anawalt, MD, commenting on the results of the #TRAVERSE trial presented at #ENDO2023.
@MedPageEndo @MedPageCardio
medpagetoday.com/meetingcove…
MedPage Endocrinology retweeted
"This is exciting and a novelty for human medicine." -- Martin Wabitsch, MD, PhD, of @uni_ulm, on the success of high-dose leptin treatment on reversing severe, early-onset #obesity in two children carrying rare genetic variants.
@MedPageEndo
medpagetoday.com/pediatrics/…
MedPage Endocrinology retweeted
"I get up every morning and I look at patient messages and half of them are due to #Mounjaro." -- @DrKarlNadolsky, of @HollandHospital, on the shortage of the #diabetes drug #tirzepatide.
medpagetoday.com/special-rep… @MedPageEndo @SophNaama
MedPage Endocrinology retweeted
All the data available reveal no significant risk pancreatitis from GLP-1 at therapy but that notion remains
There are now hundreds of authoritative experts that opine daily on the risk of GLP-1 therapies, often scaring people about the risk #pancreatitis Yet after 18 years in the clinic for #T2D there is no signal for pancreatitis in RCTs or real world data thelancet.com/journals/landi…
MedPage Endocrinology retweeted
Evidence is building that #COVID could be a risk factor for developing #diabetes, both type 1 and type 2.
@RifkaSchulmanMD @MedPageID @MedPageEndo
https://xitter.cf/t.co/8HxNAHZSvQ
MedPage Endocrinology retweeted
Effects of #dapagliflozin on #hospitalisations in people with type 2 #diabetes: post-hoc analyses of the DECLARE-TIMI 58 trial thelancet.com/journals/landi… #T2D
MedPage Endocrinology retweeted
‼️Our transplant surgeons wrote, "Attacking our complex and nuanced organ transplant system without realistic solutions only diverts time and resources from this lifesaving work" in the story that was published by @medpagetoday ➡️ tinyurl.com/3m7whcmj 👇👇 – at San Francisco, CA
MedPage Endocrinology retweeted
The cardiovascular era for GLP-1RA started with preclinical data, then was launched by LEADER in 2016 and 7 subsequent CVOTs. How and where does GLP-1 produce a CV benefit? Some thoughts #CVD #T2D #diabetes #Heartdisease #Atherosclerosis @NatRevCardiol nature.com/articles/s41569-0…
MedPage Endocrinology retweeted
Obesity Tied to Density of Food Stores Carrying Less Healthy Options, Report Finds
— Link between obesity and unhealthy food establishments holds in both rural and non-rural areas
medpagetoday.com/endocrinolo…
By @joycefr @medpagetoday
@urbaninstitute @WaxmanElaine
MedPage Endocrinology retweeted
Thank you @medpagetoday for covering our work that shows an association between metformin use and a reduced incidence of osteoarthritis. medpagetoday.com/primarycare…
MedPage Endocrinology retweeted
New #obesity drug has less weight loss and more side effects. But in a growing marketplace - the right price point may make it an option for some patients
Altimmune stock slumps ~35% amid phase 2 trial data of obesity drug pemvidutide | Seeking Alpha seekingalpha.com/news/394938…
MedPage Endocrinology retweeted
When patients enroll in #clinicaltrials, they reasonably assume that the research results will be shared with the public, physicians, and fellow patients.
But without FDA enforcement, that's not always the case.
See our piece in @medpagetoday:
medpagetoday.com/opinion/sec…
MedPage Endocrinology retweeted
"We shouldn't be scaring away people who have obesity and obesity-related complications." -- @DrKarlNadolsky commenting on new concerns about muscle loss for patients on #semaglutide (#Wegovy, #Ozempic).
medpagetoday.com/special-rep… @MedPageEndo @KristinaMFiore
MedPage Endocrinology retweeted
Does #Wegovy Shrink Muscle Mass to a concerning degree as raised by @PeterAttiaMD recently? medpagetoday.com/special-rep… Check out our comments in this @medpagetoday article
MedPage Endocrinology retweeted
In patients with NASH cirrhosis, #semaglutide did not significantly improve fibrosis or #NASH resolution vs. placebo. However, semaglutide improves metabolic syndrome, BMI, liver enzymes, and hepatic steatosis, but not liver stiffness. @DrLoomba @Mayo_liverdoc @schattenbergJ
@novonordisk @TheLancet #NAFLD
thelancet.com/journals/langa…
MedPage Endocrinology retweeted
🔥tip: GLP1s can affect absorption of other #medications
eg) Rybelsus ↑ levothyroxine absorption by 33%
If your patient is experiencing new side effects that you can't attribute directly to the GLP1, they might be absorbing more of their other medications
#medicine #endocrine
MedPage Endocrinology retweeted
Sleep deprivation causes weight gain by lowering #leptin and raising #ghrelin levels. onlinelibrary.wiley.com/doi/…
MedPage Endocrinology retweeted
Very excited to share our op-ed on the importance of medical treatment for gender nonconforming youth using a patient-centered approach without political influence @medpagetoday @genevievefri @NYCHealthSystem @SouthBKHealth medpagetoday.com/opinion/sec…
MedPage Endocrinology retweeted
Teenagers' bad sleep habits are linked to insulin resistance. onlinelibrary.wiley.com/doi/…
MedPage Endocrinology retweeted
Announcing our next IG Live! 🎉 Featuring @jeremyfaust, @arghavan_salles, & @ShikhaJainMD, this live discussion will focus on strategies to advance gender equity in the field of medicine.
Tune in on March 17 at 2pm ET! To join, follow us on IG: https://xitter.cf/t.co/lcrUUQDrCH @WIMSummit



















